Cancer research has shifted toward an evolutionary model that views tumor development as a process of clonal selection and promotion rather than a single mutagenic event. This framework, supported by decades of research from figures like Douglas Hanahan and Robert Weinberg, suggests that malignant tumors emerge when specific cell populations gain functional capabilities that allow them to outcompete others in their environment.
How the initiation-promotion model works
The foundation of this theory rests on a two-stage process: initiation and promotion. A 1947 study by Berenblum and Shubik proved that a single application of a mutagenic carcinogen can initiate cancer, but repeated treatment with an inflammatory agent, such as croton oil, is required to promote the tumor’s growth.
This model demonstrates that while a mutation may create a susceptible cell, the surrounding environment determines if that cell will actually turn into a tumor. This mirrors Darwinian evolution, where environmental pressures shape which clones survive and proliferate.
Why the microenvironment controls progression
Tumor cells don’t operate in isolation. Research by Bissell and Hines in 2011 proposed that the microenvironment acts as a restraint on cancer progression, explaining why not every mutation leads to clinical disease.
The “hallmarks of cancer” framework organizes these biological capabilities into distinct dimensions. These include the ability to sustain proliferative signaling and evade growth suppressors. Recent updates in 2011 and 2022 have expanded this view to include the role of the immune macro-environment and systemic interactions with distant organs.
What this means for future treatment
Understanding cancer as a systemic disease suggests that targeting only the tumor cells may be insufficient. Research now emphasizes the need to address the mechanisms of “tumor promotion” and the phenotypic traits that enable a cell to survive the evolutionary pressure of the body’s defenses.
Co-targeting multiple hallmarks could offer a way to disrupt the evolutionary advantage of malignant clones. This approach may reduce the likelihood of tumors developing resistance through further clonal evolution.
What is the difference between initiation and promotion?
Initiation is the first step where a mutagenic carcinogen causes a genetic change in a cell. Promotion is the subsequent process where inflammatory agents or environmental factors encourage those initiated cells to grow into a tumor.
What are the “hallmarks of cancer”?
They are a set of fundamental functional capabilities that normal cells must acquire to become malignant, such as the ability to ignore growth suppressors and sustain their own proliferative signaling.
